Nomura Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Buy |
58,545
+2,866
| +5% | +$594K | 0.02% | 432 |
|
|
2026
Q1 | $12.5M | Buy |
55,679
+626
| +1% | +$156K | 0.03% | 395 |
|
|
2025
Q4 | $13.3M | Buy |
55,053
+2,099
| +4% | +$537K | 0.03% | 378 |
|
|
2025
Q3 | $14.5M | Buy |
52,954
+5,555
| +12% | +$1.52M | 0.04% | 356 |
|
|
2025
Q2 | $12.2M | Buy |
47,399
+2,186
| +5% | +$521K | 0.03% | 385 |
|
|
2025
Q1 | $10.1M | Buy |
45,213
+1,969
| +5% | +$460K | 0.03% | 414 |
|
|
2024
Q4 | $9.89M | Buy |
43,244
+335
| +0.8% | +$80.7K | 0.03% | 408 |
|
|
2024
Q3 | $10.5M | Buy |
42,909
+2,064
| +5% | +$461K | 0.03% | 396 |
|
|
2024
Q2 | $7.82M | Buy |
40,845
+1,486
| +4% | +$302K | 0.03% | 433 |
|
|
2024
Q1 | $7.79M | Buy |
39,359
+1,871
| +5% | +$343K | 0.03% | 438 |
|
|
2023
Q4 | $6.45M | Buy |
37,488
+1,643
| +5% | +$252K | 0.03% | 468 |
|
|
2023
Q3 | $5.3M | Sell |
35,845
-712
| -2% | -$129K | 0.02% | 485 |
|
|
2023
Q2 | $7.99M | Sell |
36,557
-450
| -1% | -$100K | 0.04% | 397 |
|
|
2023
Q1 | $8.1M | Buy |
37,007
+1,096
| +3% | +$238K | 0.04% | 380 |
|
|
2022
Q4 | $7.47M | Buy |
35,911
+1,463
| +4% | +$321K | 0.04% | 382 |
|
|
2022
Q3 | $7.52M | Buy |
34,448
+783
| +2% | +$178K | 0.05% | 356 |
|
|
2022
Q2 | $7.06M | Buy |
33,665
+1,936
| +6% | +$412K | 0.04% | 371 |
|
|
2022
Q1 | $7.69M | Buy |
31,729
+1,091
| +4% | +$264K | 0.04% | 382 |
|
|
2021
Q4 | $7.98M | Buy |
30,638
+1,670
| +6% | +$433K | 0.04% | 375 |
|
|
2021
Q3 | $7.63M | Buy |
28,968
+761
| +3% | +$208K | 0.04% | 361 |
|
|
2021
Q2 | $6.95M | Sell |
28,207
-736
| -3% | -$155K | 0.04% | 394 |
|
|
2021
Q1 | $5.62M | Buy |
28,943
+1,287
| +5% | +$258K | 0.04% | 423 |
|
|
2020
Q4 | $5.88M | Buy |
27,656
+1,299
| +5% | +$259K | 0.04% | 385 |
|
|
2020
Q3 | $4.52M | Sell |
26,357
-80
| -0.3% | -$14.8K | 0.03% | 403 |
|
|
2020
Q2 | $5.08M | Sell |
26,437
-557
| -2% | -$91.1K | 0.04% | 346 |
|
|
2020
Q1 | $3.98M | Buy |
26,994
+1,930
| +8% | +$307K | 0.04% | 356 |
|
|
2019
Q4 | $3.88M | Buy |
25,064
+889
| +4% | +$128K | 0.03% | 420 |
|
|
2019
Q3 | $3.27M | Buy |
24,175
+1,403
| +6% | +$184K | 0.03% | 433 |
|
|
2019
Q2 | $2.78M | Sell |
22,772
-1,279
| -5% | -$142K | 0.03% | 468 |
|
|
2019
Q1 | $2.5M | Buy |
24,051
+527
| +2% | +$54.4K | 0.02% | 495 |
|
|
2018
Q4 | $2.68M | Buy |
23,524
+757
| +3% | +$81.1K | 0.03% | 421 |
|
|
2018
Q3 | $2.63M | Buy |
22,767
+1,252
| +6% | +$137K | 0.03% | 466 |
|
|
2018
Q2 | $2.23M | Sell |
21,515
-25
| -0.1% | -$2.53K | 0.02% | 518 |
|
|
2018
Q1 | $2.12M | Buy |
21,540
+1,938
| +10% | +$183K | 0.02% | 517 |
|
|
2017
Q4 | $1.66M | Buy |
19,602
+27
| +0.1% | +$2.23K | 0.02% | 579 |
|
|
2017
Q3 | $1.51M | Buy |
19,575
+1,612
| +9% | +$123K | 0.02% | 568 |
|
|
2017
Q2 | $1.4M | Sell |
17,963
-287
| -2% | -$20.5K | 0.02% | 575 |
|
|
2017
Q1 | $1.31M | Buy |
18,250
+1,830
| +11% | +$126K | 0.02% | 600 |
|
|
2016
Q4 | $1.02M | Hold |
16,420
| – | – | 0.02% | 655 |
|
|
2016
Q3 | $1.06M | Buy |
16,420
+900
| +6% | +$59.9K | 0.02% | 621 |
|
|
2016
Q2 | $981K | Buy |
15,520
+200
| +1% | +$11.8K | 0.02% | 612 |
|
|
2016
Q1 | $886K | Hold |
15,320
| – | – | 0.02% | 662 |
|
|
2015
Q4 | $823K | Buy |
15,320
+100
| +0.7% | +$5.64K | 0.02% | 675 |
|
|
2015
Q3 | $776K | Buy |
15,220
+1,000
| +7% | +$53.8K | 0.02% | 679 |
|
|
2015
Q2 | $802K | Hold |
14,220
| – | – | 0.01% | 685 |
|
|
2015
Q1 | $1.02M | Sell |
14,220
-320
| -2% | -$20.8K | 0.02% | 602 |
|
|
2014
Q4 | $825K | Hold |
14,540
| – | – | 0.01% | 665 |
|
|
2014
Q3 | $716K | Sell |
14,540
-25,740
| -64% | -$1.31M | 0.01% | 678 |
|
|
2014
Q2 | $2.04M | Buy |
40,280
+260
| +0.6% | +$12.9K | 0.04% | 369 |
|
|
2014
Q1 | $1.79M | Buy |
40,020
+25,740
| +180% | +$1.16M | 0.03% | 403 |
|
|
2013
Q4 | $672K | Sell |
14,280
-2,230
| -14% | -$113K | 0.01% | 692 |
|
|
2013
Q3 | $872K | Hold |
16,510
| – | – | 0.02% | 592 |
|
|
2013
Q2 | $745K | Buy |
+16,510
| New | +$783K | 0.01% | 632 |
|
Other funds holding RMD
Nomura Asset Management's RMD Position: Q2 2026 in Review
Nomura Asset Management increased its ResMed (RMD) stake by 5.1% in Q2 2026, buying an estimated $594K and bringing the position to 58,545 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #432.
Nomura Asset Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.5M in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Nomura Asset Management held 58,545 shares of ResMed worth $11.4M as of Q2 2026.
- Nomura Asset Management bought 2,866 ResMed shares in Q2 2026, an estimated $594K.
- ResMed made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #432 holding.
- Nomura Asset Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- Nomura Asset Management's ResMed position peaked at $14.5M in Q3 2025.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.